LLY Collar Strategy
LLY (Eli Lilly and Company), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer.
LLY (Eli Lilly and Company) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $1.09T, a trailing P/E of 38.66, a beta of 0.50 versus the broader market, a 52-week range of 763.3-1292.65, average daily share volume of 2.8M, a public-listing history dating back to 1972, approximately 50K full-time employees. These structural characteristics shape how LLY stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.50 indicates LLY has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 38.66 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. LLY pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a collar on LLY?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
LLY snapshot
As of September 29, 2026, spot at $1,183.64, ATM IV 40.14%, IV rank 61.98%, expected move 11.51%. The collar on LLY below is built from the September 29, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 31-day expiry.
Why this collar structure on LLY specifically: IV regime affects collar pricing on both sides; mid-range LLY IV at 40.14% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 11.51% (roughly $136.23 on the underlying). The 31-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LLY expiries trade a higher absolute premium for lower per-day decay. Position sizing on LLY should anchor to the underlying notional of $1,183.64 per share and to the trader's directional view on LLY stock.
LLY collar setup
The LLY collar below is built from the September 29, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LLY at $1,183.64 on that close, the first option leg uses a $1,245.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LLY chain at a 31-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LLY shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $1,183.64 | long |
| Sell 1 | Call | $1,245.00 | $33.98 |
| Buy 1 | Put | $1,125.00 | $31.63 |
LLY collar risk and reward
- Net Premium / Debit
- -$118,129.00
- Max Profit (per contract)
- $6,371.00
- Max Loss (per contract)
- -$5,629.00
- Breakeven(s)
- $1,181.29
- Risk / Reward Ratio
- 1.132
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
LLY collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on LLY. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$5,629.00 |
| $261.72 | -77.9% | -$5,629.00 |
| $523.43 | -55.8% | -$5,629.00 |
| $785.13 | -33.7% | -$5,629.00 |
| $1,046.84 | -11.6% | -$5,629.00 |
| $1,308.55 | +10.6% | +$6,371.00 |
| $1,570.26 | +32.7% | +$6,371.00 |
| $1,831.97 | +54.8% | +$6,371.00 |
| $2,093.68 | +76.9% | +$6,371.00 |
| $2,355.38 | +99.0% | +$6,371.00 |
When traders use collar on LLY
Collars on LLY hedge an existing long LLY stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
LLY thesis for this collar
The market-implied 1-standard-deviation range for LLY extends from approximately $1,047.41 on the downside to $1,319.87 on the upside. A LLY collar hedges an existing long LLY position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current LLY IV rank near 61.98% is mid-range against its 1-year distribution, so the IV signal is neutral; the collar thesis on LLY should anchor more to the directional view and the expected-move geometry. As a Healthcare name, LLY options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LLY-specific events.
LLY collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LLY positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LLY alongside the broader basket even when LLY-specific fundamentals are unchanged. Always rebuild the position from current LLY chain quotes before placing a trade.
Frequently asked questions
- What is a collar on LLY?
- A collar on LLY is the collar strategy applied to LLY (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With LLY stock at $1,183.64 on the September 29, 2026 close, the strikes shown on this page are snapped to the nearest listed LLY chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are LLY collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the LLY collar priced from the September 29, 2026 end-of-day chain at a 30-day expiry (ATM IV 40.14%), the computed maximum profit is $6,371.00 per contract and the computed maximum loss is -$5,629.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LLY collar?
- The breakeven for the LLY collar priced on this page is roughly $1,181.29 at expiration, derived from the September 29, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LLY market-implied 1-standard-deviation expected move in the same options snapshot is approximately 11.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on LLY?
- Collars on LLY hedge an existing long LLY stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current LLY implied volatility affect this collar?
- LLY ATM IV is at 40.14% with IV rank near 61.98%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.